Form D · Biotechnology
Lionheart Health, Inc.
Huntington Beach, CA · CIK 0002156758
Offering snapshot reported Oct 7, 2026 · SEC filing
- Reported sold
- $388K Offering amount: $3M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2026 | Initial | $387,500 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600360
Source: Form D, filed Oct 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dr. Sanjay Bhojraj | Director, Executive |
| Chad Hacker | Director |
| Scott Hoots | Executive |
| Scott Jordan | Executive |
| Brian Lasater | Executive |
| Howard John Leonhardt | Director, Executive |
| Dr. Leslie Miller | Director, Executive |
| Mike Robinson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
21060 Pacific City Cir 6115
Huntington Beach, CA, 92648
Phone: (424) 291-2133
Huntington Beach, CA, 92648
Phone: (424) 291-2133